Want to join the conversation?
$A expects FY16 revenue of $4.16-4.18Bil and non-GAAP earnings of $1.88-1.92 per share. 3Q16 revenue is expected to be in the range of $1.03-1.05Bil and non-GAAP earnings are expected to be $0.45-0.47 per share. $A has upped its full-year operating cash flow guidance from $650MM to $740MM, with no change to its CapEx guidance of $140MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?